Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | VP, Strategic Communications | May 08, 2006 | May 09, 2006 |
| YIELD10 BIOSCIENCE, INC.YTEN · Entity 88195 | VP Planning and Communications | August 15, 2024 | August 19, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VERTEX PHARMACEUTICALS INC / MA
Report date May 08, 2006 · Filed May 09, 2006
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,199 |
Ending reported balance
After 2006-05-08 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2006-05-08 · Exercise / conversion · Acquired 1,000 · Balance 47,199 Row 2 · 2006-05-08 · Sale · Disposed 1,000 · Balance 46,199 F1: Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1. Row 3 · 2006-05-08 · Exercise / conversion · Acquired 1,250 · Balance 47,449 Row 4 · 2006-05-08 · Sale · Disposed 1,250 · Balance 46,199 F1: Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $15.56 · Expires 2006-12-11 | Direct | 279,183 |
Reported balance
After 2006-05-08 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2006-05-08 · Grant · Disposed 1,000 · Balance 279,183 F2: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $13.67 · Expires 2007-12-11 | Direct | 277,933 |
Reported balance
After 2006-05-08 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2006-05-08 · Grant · Disposed 1,250 · Balance 277,933 F3: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/97. |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 6,793 |
Reported balance
Holding disclosure · report date 2006-05-08 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 6,793 |
| Common StockSEC Table I · non-derivative | IndirectOwned by husband | 10 |
Reported balance
Holding disclosure · report date 2006-05-08 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 10 |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1.
F2: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96.
F3: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/97.
YIELD10 BIOSCIENCE, INC.
Report date August 15, 2024 · Filed August 19, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,867 |
Reported balance
After 2024-08-15 transaction · row 1
1 source rowRow 1 · 2024-08-15 · Tax withholding · Disposed 731 · Balance 5,867 F1: Represents shares withheld in payment of withholding taxes upon partial vesting of RSUs granted 2/15/2024. F2: Share numbers reflect the 1:24 reverse stock split effected on 5/2/2024. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 2,056 |
Reported balance
Holding disclosure · report date 2024-08-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,056 F3: Shares acquired as Issuer matching contribution under the Yield10 Bioscience, Inc. 401(k) Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld in payment of withholding taxes upon partial vesting of RSUs granted 2/15/2024.
F2: Share numbers reflect the 1:24 reverse stock split effected on 5/2/2024.
F3: Shares acquired as Issuer matching contribution under the Yield10 Bioscience, Inc. 401(k) Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2024 Filed Aug 19, 2024 20:11 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | Tax withholdingCommon Stock | 731 | $1.50 | $1,096.50 |
DisclosureSEC source: 0001104659-24-090983 · tm2422096-3_4seq1.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning and Communications 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,867 F1 · shares: Represents shares withheld in payment of withholding taxes upon partial vesting of RSUs granted 2/15/2024. F2 · shares: Share numbers reflect the 1:24 reverse stock split effected on 5/2/2024. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 18:25 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | GrantCommon Stock | 100,000 | $0.30 | $30,000.00 |
DisclosureSEC source: 0001104659-24-025032 · tm246574-3_4seq1.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP, Planning and Corporate Com 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,326 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 50% of the shares on 8/15/2024 and the remaining 50% on 2/15/2025. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 15:56 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | Tax withholdingCommon Stock | 1,029 | $3.59 | $3,694.11 |
DisclosureSEC source: 0001628280-23-003495 · wf-form4_167640816918910.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning and Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,323 F1 · shares: Represents shares withheld in payment of withholding taxes upon partial vesting of RSUs granted 2/10/2022 Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 16:28 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | GrantStock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001628280-23-001036 · wf-form4_167364530810770.xml · derivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning and Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2033-01-12 F1 · derivative.exercise_date: These options will vest and become exercisable in equal quarterly installments over 4 years from 1/12/2023, beginning on 4/12/2023 and ending on 1/12/2027. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 11:32 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | Tax withholdingCommon Stock | 864 | $2.68 | $2,315.52 |
DisclosureSEC source: 0001104659-22-089863 · tm2223300-3_4seq1.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning and Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,352 F1 · shares: Represents shares withheld in payment of withholding taxes upon partial vesting of RSUs granted 2/10/2022. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 19:53 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | Tax withholdingCommon Stock | 366 | $4.25 | $1,555.50 |
DisclosureSEC source: 0001104659-22-030200 · tm228387-2_4seq1.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning and Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,216 F1 · shares: Represents shares withheld in payment of withholding taxes upon partial vesting of RSUs granted 3/1/2021. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 14:33 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | GrantStock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $3.83 | $0.00 |
DisclosureSEC source: 0001179110-22-001143 · edgar.xml · derivative · entry 3 BRUM LYNNE H · CIK 0001197017 · VP Planning and Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2032-02-10 F3 · derivative.exercise_date: These options will vest and become exercisable in equal quarterly installments over 4 years from 2/10/2022, beginning on 5/10/2022 and ending on 2/10/2026. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 14:33 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | GrantCommon Stock | 5,891 | $3.83 | $22,562.53 |
DisclosureSEC source: 0001179110-22-001143 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning and Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,582 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 50% of the shares on 8/10/2022 and the remaining 50% on 2/10/2023. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 19:52 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | GrantStock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001179110-21-009009 · edgar.xml · derivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning and Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2031-09-28 F1 · derivative.exercise_date: These options will vest and become exercisable in equal quarterly installments over 4 years from 9/28/2021, beginning on 12/28/2021 and ending on 9/28/2025. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 17:17 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | Tax withholdingCommon Stock | 307 | $6.71 | $2,059.97 |
DisclosureSEC source: 0001179110-21-008614 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning and Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,691 F1 · shares: Represents shares withheld in payment of withholding taxes upon partial vesting of RSUs granted 3/1/2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 13:54 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | GrantCommon Stock | 2,092 | $16.03 | $33,534.76 |
DisclosureSEC source: 0001179110-21-002637 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning & Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,998 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 50% of the shares on 09/01/2021 and the remaining 50% on 03/01/2022. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 11:13 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | Tax withholdingCommon Stock | 693 | $22.77 | $15,779.61 |
DisclosureSEC source: 0001179110-21-001668 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning & Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,906 F1 · shares: Represents shares withheld in payment of withholding taxes upon vesting of RSUs granted 2/11/20. Read SEC document |
| January 25, 2021 Filed Jan 27, 2021 10:40 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | GrantStock Option (right to buy) · Derivative | 11,500 | $0.00 Strike: $16.49 | $0.00 |
DisclosureSEC source: 0001179110-21-000864 · edgar.xml · derivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning & Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 Underlying: Common Stock · 11,500 shares Expires 2031-01-25 F1 · derivative.exercise_date: These options will vest and become exercisable in equal quarterly installments over 4 years from 1/25/2021, beginning on 4/25/2021 and ending on 1/25/2025. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 18:00 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | Tax withholdingCommon Stock | 587 | $6.55 | $3,844.85 |
DisclosureSEC source: 0001179110-20-009011 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning & Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,599 F1 · shares: Represents shares withheld in payment of withholding taxes upon vesting of RSUs granted 2/11/20. Read SEC document |
| May 28, 2020 Filed May 29, 2020 15:54 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | GrantStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $5.86 | $0.00 |
DisclosureSEC source: 0001179110-20-006704 · edgar.xml · derivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning & Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2030-05-28 F1 · derivative.exercise_date: These options will vest and become exercisable in equal quarterly installments over 4 years from 5/28/2020, beginning on 8/28/2020 and ending on 5/28/2024. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 16:10 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-001559 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning & Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,186 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 50% of the shares on 8/11/20 and the remaining 50% on 2/11/21. F2 · balance_after: All share numbers reported reflect the 1-for-40 reverse stock split effected on January 15, 2020. Read SEC document |
| May 22, 2019 Filed May 23, 2019 16:28 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001179110-19-006574 · edgar.xml · derivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning & Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2029-05-22 F1 · derivative.exercise_date: These options will vest and become exercisable in equal quarterly installments over 4 years from 5/22/19, beginning on 8/22/2019 and ending on 5/22/2023. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 19:38 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | Tax withholdingCommon Stock | 679 | $1.16 | $787.64 |
DisclosureSEC source: 0001179110-19-004747 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning & Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,469 F1 · shares: Represents shares withheld in payment of withholding taxes upon vesting of RSUs granted 4/1/15. Read SEC document |
| May 23, 2018 Filed May 25, 2018 10:57 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001179110-18-007514 · edgar.xml · derivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning & Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-05-23 F1 · derivative.exercise_date: These options will vest and become exercisable in equal quarterly installments over 4 years from 5/23/18, beginning on 8/23/2018 and ending on 5/23/2022. Read SEC document |
| April 01, 2018 Filed Apr 3, 2019 19:38 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | Tax withholdingCommon Stock | 739 | $1.95 | $1,441.05 |
DisclosureSEC source: 0001179110-19-004746 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning & Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,208 F1 · shares: Represents shares withheld in payment of withholding taxes upon vesting of RSUs granted 4/1/15. F2 · balance_after: Includes 1,958 restricted stock units. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 18:34 UTC | YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 | Tax withholdingCommon Stock | 7,392 | $0.37 | $2,735.04 |
DisclosureSEC source: 0001179110-17-005671 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning & Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,474 F1 · shares: Represents shares withheld in payment of withholding taxes upon vesting of RSUs granted 4/1/15. Read SEC document |
| October 26, 2016 Filed Oct 28, 2016 16:02 UTC | YIELD10 BIOSCIENCE, INC. MBLX · Entity 88195 | GrantStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.53 | $0.00 |
DisclosureSEC source: 0001179110-16-030981 · edgar.xml · derivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP Planning & Comms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2026-10-26 F1 · derivative.exercise_date: This stock option will vest and become exercisable in 4 equal semi-annual installments over 2 years from 10/26/16. Read SEC document |
| May 08, 2006 Filed May 9, 2006 20:40 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 1,250 | $0.00 Strike: $13.67 | $0.00 |
DisclosureSEC source: 0000875320-06-000042 · edgar.xml · derivative · entry 8 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,933 Underlying: Common Stock · 1,250 shares Expires 2007-12-11 F3 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/97. Read SEC document |
| May 08, 2006 Filed May 9, 2006 20:40 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 1,000 | $0.00 Strike: $15.56 | $0.00 |
DisclosureSEC source: 0000875320-06-000042 · edgar.xml · derivative · entry 7 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,183 Underlying: Common Stock · 1,000 shares Expires 2006-12-11 F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96. Read SEC document |
| May 08, 2006 Filed May 9, 2006 20:40 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 1,250 | $36.57 | $45,712.50 |
DisclosureSEC source: 0000875320-06-000042 · edgar.xml · nonDerivative · entry 4 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,199 F1 · kind: Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 08, 2006 Filed May 9, 2006 20:40 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 1,250 | $13.67 | $17,087.50 |
DisclosureSEC source: 0000875320-06-000042 · edgar.xml · nonDerivative · entry 3 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2006 Filed May 9, 2006 20:40 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 1,000 | $36.57 | $36,570.00 |
DisclosureSEC source: 0000875320-06-000042 · edgar.xml · nonDerivative · entry 2 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,199 F1 · kind: Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 08, 2006 Filed May 9, 2006 20:40 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 1,000 | $15.56 | $15,560.00 |
DisclosureSEC source: 0000875320-06-000042 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2006 Filed May 2, 2006 17:39 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 1,250 | $0.00 Strike: $13.67 | $0.00 |
DisclosureSEC source: 0000875320-06-000040 · edgar.xml · derivative · entry 8 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,183 Underlying: Common Stock · 1,250 shares Expires 2007-12-11 F3 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/97. Read SEC document |
| May 01, 2006 Filed May 2, 2006 17:39 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 1,000 | $0.00 Strike: $15.56 | $0.00 |
DisclosureSEC source: 0000875320-06-000040 · edgar.xml · derivative · entry 7 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,433 Underlying: Common Stock · 1,000 shares Expires 2006-12-11 F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96. Read SEC document |
| May 01, 2006 Filed May 2, 2006 17:39 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 1,250 | $35.77 | $44,712.50 |
DisclosureSEC source: 0000875320-06-000040 · edgar.xml · nonDerivative · entry 4 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,199 F1 · kind: Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 01, 2006 Filed May 2, 2006 17:39 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 1,250 | $13.67 | $17,087.50 |
DisclosureSEC source: 0000875320-06-000040 · edgar.xml · nonDerivative · entry 3 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2006 Filed May 2, 2006 17:39 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 1,000 | $35.77 | $35,770.00 |
DisclosureSEC source: 0000875320-06-000040 · edgar.xml · nonDerivative · entry 2 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,199 F1 · kind: Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 01, 2006 Filed May 2, 2006 17:39 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 1,000 | $15.56 | $15,560.00 |
DisclosureSEC source: 0000875320-06-000040 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2006 Filed Apr 25, 2006 17:41 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 1,000 | $0.00 Strike: $15.56 | $0.00 |
DisclosureSEC source: 0000875320-06-000039 · edgar.xml · derivative · entry 5 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,433 Underlying: Common Stock · 1,000 shares Expires 2006-12-11 F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96. Read SEC document |
| April 24, 2006 Filed Apr 25, 2006 17:41 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 1,000 | $38.33 | $38,330.00 |
DisclosureSEC source: 0000875320-06-000039 · edgar.xml · nonDerivative · entry 2 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,199 F1 · kind: Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1. Read SEC document |
| April 24, 2006 Filed Apr 25, 2006 17:41 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 1,000 | $15.56 | $15,560.00 |
DisclosureSEC source: 0000875320-06-000039 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 17, 2006 Filed Apr 18, 2006 18:06 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 1,000 | $0.00 Strike: $15.56 | $0.00 |
DisclosureSEC source: 0000875320-06-000037 · edgar.xml · derivative · entry 5 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,433 Underlying: Common Stock · 1,000 shares Expires 2006-12-11 F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96. Read SEC document |
| April 17, 2006 Filed Apr 18, 2006 18:06 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 1,000 | $35.79 | $35,790.00 |
DisclosureSEC source: 0000875320-06-000037 · edgar.xml · nonDerivative · entry 2 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,199 F1 · kind: Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1. Read SEC document |
| April 17, 2006 Filed Apr 18, 2006 18:06 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 1,000 | $15.56 | $15,560.00 |
DisclosureSEC source: 0000875320-06-000037 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 10, 2006 Filed Apr 11, 2006 17:35 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 1,000 | $0.00 Strike: $15.56 | $0.00 |
DisclosureSEC source: 0000875320-06-000036 · edgar.xml · derivative · entry 5 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,433 Underlying: Common Stock · 1,000 shares Expires 2006-12-11 F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96. Read SEC document |
| April 10, 2006 Filed Apr 11, 2006 17:35 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 1,000 | $33.92 | $33,920.00 |
DisclosureSEC source: 0000875320-06-000036 · edgar.xml · nonDerivative · entry 2 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,199 F1 · kind: Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1. Read SEC document |
| April 10, 2006 Filed Apr 11, 2006 17:35 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 1,000 | $15.56 | $15,560.00 |
DisclosureSEC source: 0000875320-06-000036 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2006 Filed Apr 4, 2006 15:16 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 1,000 | $0.00 Strike: $15.56 | $0.00 |
DisclosureSEC source: 0000875320-06-000034 · edgar.xml · derivative · entry 5 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,433 Underlying: Common Stock · 1,000 shares Expires 2006-12-11 F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96. Read SEC document |
| April 03, 2006 Filed Apr 4, 2006 15:16 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 1,000 | $35.98 | $35,980.00 |
DisclosureSEC source: 0000875320-06-000034 · edgar.xml · nonDerivative · entry 2 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,199 F1 · kind: Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1. Read SEC document |
| April 03, 2006 Filed Apr 4, 2006 15:16 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 1,000 | $15.56 | $15,560.00 |
DisclosureSEC source: 0000875320-06-000034 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2006 Filed Mar 28, 2006 21:16 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 1,000 | $0.00 Strike: $15.56 | $0.00 |
DisclosureSEC source: 0000875320-06-000033 · edgar.xml · derivative · entry 5 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,433 Underlying: Common Stock · 1,000 shares Expires 2006-12-11 F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96. Read SEC document |
| March 27, 2006 Filed Mar 28, 2006 21:16 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 1,000 | $15.56 | $15,560.00 |
DisclosureSEC source: 0000875320-06-000033 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2006 Filed Mar 27, 2006 16:57 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 1,988 | $36.56 | $72,681.28 |
DisclosureSEC source: 0000875320-06-000031 · edgar.xml · nonDerivative · entry 1 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,199 F1 · kind: Transaction made pursuant to Ms. Brum's company approved trading plan established under Rule 10b5-1. Read SEC document |
| March 20, 2006 Filed Mar 21, 2006 17:38 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 1,000 | $0.00 Strike: $15.56 | $0.00 |
DisclosureSEC source: 0000875320-06-000029 · edgar.xml · derivative · entry 6 BRUM LYNNE H · CIK 0001197017 · VP, Strategic Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,433 Underlying: Common Stock · 1,000 shares Expires 2006-12-11 F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 12/12/96. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.